1. Cambridge, D., and Whiting, M. V. (1989). Characterising the 5-HT receptor mediating coronary vasodilation in the dog using tryptamine analogues. Br. J. Pharmacol. 98 (Suppl.), 750 P.
2. Connor, H. E., Feniuk, W., Humphrey, P. P. A., and Perren M. J. (1986). 5-Carboxamidotryptamine is a selective agonist at 5-hydroxytryptamine receptors mediating vasodilation and tachycardia in anaesthetised cats. Br. J. Pharmacol. 87: 417–426.
3. Feniuk, W., Humphrey, P. P. A., and Perren, M. J. (1989). The selective carotid arterial vasoconstrictor action of GR43175 in anaesthetised dogs. Br. J. Pharmacol. 96: 83–90.
4. Humphrey, P. P. A., Feniuk, W., Perren, M. J., Connor, H. E., Oxford, W. A., Coates, I. H., and Butina, D. (1988). GR43175, a selective agonist for the 5-HT, -like receptor in dog isolated saphenous vein. Br. J. Pharmacol. 94: 1123–1132.
5. Martin, G. R., Leff, P., Cambridge, D., and Barrett, V. J. (1987). Comparative analysis of two types of 5-hydroxytryptamine receptor mediating vasorelaxation: differential classification using tryptamines. Naunyn Schmiedebergs Arch. Pharmacol. 336: 365–373.